Wednesday 24th February 2021
|Text too small?|
The Group is on target to achieve global case sales for the full year of 3,391,000, up 3% on last year. Based on prevailing exchange rates, the Group forecasts a 2021 Operating Profit result of $67 million, up on last year’s performance by 10%.
A record Operating NPAT of $43.1 million was generated compared to $34.4 million for the same period the previous year. Operating EBIT of $64.5 million is $11.0 million higher than for the same period the previous year.
Delegat achieved Operating Revenue of $172.8 million on global case sales of 1,862,000 in the six month period. Revenue is up $16.1 million on the same period last year due to a 7% increase in global case sales and the favourable impact of market and product mix.
Operating Gross Profit is up 10% on the same period last year. This is due to the increased case sales and favourable impact of market and product mix, which have offset an unfavourable impact of foreign exchange rate changes. Operating expenses (before NZ IFRS adjustments) at $26.3 million are $2.8 million lower compared to the same period in the previous year. This is primarily due to the impact of COVID-19 restrictions in the current year, whereby travel, entertainment and other operating expenses have been restricted in most markets.
Please see the links below for details:
No comments yet
BIF - Acquires shares in Hot Lime Labs
RUA - Cann Group granted TGA GMP for Mildura facility
AFI - Invitation to Results Webcast
PFI Share Buyback Programme to Pause
Greenfern Industries Limited ("GFI") - Late Annual Report
FSF - Monthly Allotment/ Redemption Notice
1st July 2022 Morning Report
General Capital Releases 2022 Annual Report
Fonterra, NZX, EEX confirm GDT strategic partnership
BIF - Annual Report 2022